|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0034897,
umls-concept:C0087111,
umls-concept:C0144576,
umls-concept:C0205179,
umls-concept:C0205225,
umls-concept:C0205276,
umls-concept:C0278701,
umls-concept:C0678226,
umls-concept:C0920321,
umls-concept:C1285530,
umls-concept:C1457887,
umls-concept:C1517927,
umls-concept:C1519810,
umls-concept:C1559154
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-8-19
|
|
pubmed:abstractText |
To establish the maximum tolerated dose and dose-limiting toxicity of chemoradiation with paclitaxel (PTX) and cisplatin (CDDP) for patients with local symptoms due to unresectable primary advanced or locally recurrent gastric adenocarcinoma located at left-upper abdomen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1432-0843
|
|
pubmed:author |
pubmed-author:HirabayashiNaokiN,
pubmed-author:IshikuraSatoshiS,
pubmed-author:KimuraMasayukiM,
pubmed-author:KoderaYasuhiroY,
pubmed-author:MiyashitaYumiY,
pubmed-author:NagataNaokiN,
pubmed-author:ObaKojiK,
pubmed-author:SakamotoJunichiJ,
pubmed-author:TakahashiNaotoN,
pubmed-author:TsuburayaAkiraA,
pubmed-author:YoshidaKazuhiroK,
pubmed-author:YoshikawaTakakiT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1071-7
|
|
pubmed:meshHeading |
pubmed-meshheading:19283353-Adenocarcinoma,
pubmed-meshheading:19283353-Aged,
pubmed-meshheading:19283353-Cisplatin,
pubmed-meshheading:19283353-Female,
pubmed-meshheading:19283353-Humans,
pubmed-meshheading:19283353-Male,
pubmed-meshheading:19283353-Maximum Tolerated Dose,
pubmed-meshheading:19283353-Middle Aged,
pubmed-meshheading:19283353-Neoplasm Recurrence, Local,
pubmed-meshheading:19283353-Paclitaxel,
pubmed-meshheading:19283353-Palliative Care,
pubmed-meshheading:19283353-Radiotherapy,
pubmed-meshheading:19283353-Stomach Neoplasms,
pubmed-meshheading:19283353-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma.
|
|
pubmed:affiliation |
Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-Ku, Yokohama 241-0815, Japan, yoshikawat@kcch.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
